Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TRACON Pharmaceuticals

TRACON Pharmaceuticals
2004 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
TCON STOCK SYMBOL
$4.30 SHARE PRICE (As of Thursday Closing)
Description

TRACON Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration (wet AMD). The company's pipeline consists of product candidates such as TRC105, TRC102, TRC253, TRC694, and TRC205. The lead product TRC105 is an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or programmed cell death protein 1 pathway.

Formerly Known As
Lexington Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 4350 La Jolla Village Drive
  • Suite 800
  • San Diego, CA 92122
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TRACON Pharmaceuticals’s full profile, request a free trial.

TRACON Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.07 - $17.30 $17.6M $2.93 -$8.90 386K 4.1M

TRACON Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value (6,361) (22,009) 30,124 52,024
Revenue 0 3,000 8,755 3,449
EBITDA (26,192) (34,700) (18,169) (25,795)
Net Income (26,494) (34,959) (19,103) (27,008)
Total Assets 21,212 40,648 36,130 45,730
Total Debt 5,972 6,427 7,440 7,463
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TRACON Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore TRACON Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

TRACON Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore TRACON Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

TRACON Pharmaceuticals Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenerx Formerly VC-backed Rockville, MD 0 000.00 00000000 000.00
00000 00000 000000 Venture Capital-Backed Geneva, Switzerland 000 00000 0000000000 0 00000
0000000 0000000000 Venture Capital-Backed Plymouth Meeting, PA 00 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Groningen, Netherlands 0 00000 0000000000 00000
To view this company’s complete list of competitors, request access »

TRACON Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore TRACON Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

TRACON Pharmaceuticals Executive Team (9)

Name Title Board
Seat
Contact
Info
Charles Theuer MD Chief Executive Officer & Chief Financial Officer
Mark Wiggins Executive
Bonne Adams Executive Vice President
Sharon Real Ph.D Executive Vice President
Jennifer Ellis Vice President, Quality Assurance

3 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

TRACON Pharmaceuticals Board Members (13)

Name Representing Role Since Contact
Info
Kenneth Galbraith Self Board Member 000 0000
Martin Martin Self Board Member 000 0000
Martin Mattingly TRACON Pharmaceuticals Board Member 000 0000
Paul Walker New Enterprise Associates Board Member 000 0000
Rainer Twiford Ph.D Brookline Group Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »